 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for TRAF2 |
 Gene summary |
| Basic gene information | Gene symbol | TRAF2 |
| Gene name | TNF receptor-associated factor 2 | |
| Synonyms | MGC:45012|TRAP|TRAP3 | |
| Cytomap | UCSC genome browser: 9q34 | |
| Type of gene | protein-coding | |
| RefGenes | NM_021138.3, | |
| Description | E3 ubiquitin-protein ligase TRAF2tumor necrosis factor type 2 receptor associated protein 3tumor necrosis factor type 2 receptor-associated protein 3 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 601895 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000127191 | ||
| HPRD : 03538 | ||
| Vega : OTTHUMG00000020952 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_TRAF2 | |
| BioGPS: 7186 | ||
| Pathway | NCI Pathway Interaction Database: TRAF2 | |
| KEGG: TRAF2 | ||
| REACTOME: TRAF2 | ||
| Pathway Commons: TRAF2 | ||
| Context | iHOP: TRAF2 | |
| ligand binding site mutation search in PubMed: TRAF2 | ||
| UCL Cancer Institute: TRAF2 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | CervixTestis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | CESCTGCT | |
| Reference showing the relevant tissue of TRAF2 | ||
| Description by TissGene annotations | Protective TissGene in OS Cancer gene TissgsLTS | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 11907583 | GO:0042981 | regulation of apoptotic process | 11907583 | GO:0043507 | positive regulation of JUN kinase activity | 11907583 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 11279055 | GO:0051865 | protein autoubiquitination | 20577214 | GO:0070534 | protein K63-linked ubiquitination | 15258597 | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 11907583 | GO:0042981 | regulation of apoptotic process | 11907583 | GO:0043507 | positive regulation of JUN kinase activity | 11907583 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 11279055 | GO:0051865 | protein autoubiquitination | 20577214 | GO:0070534 | protein K63-linked ubiquitination | 15258597 |
| Top |
| TissGeneExp for TRAF2 |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| STAD | 0.037770242 | -1.125389133 | 1.163159375 | 1.01E-11 | 2.21E-09 |
| ESCA | -0.14059936 | -1.262044815 | 1.121445455 | 1.12E-05 | 0.000996352 |
| Top |
| TissGene-miRNA for TRAF2 |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for TRAF2 |
| TissGeneSNV for TRAF2 |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.D488N | STAD | 1 |
| p.E280K | BLCA | 1 |
| p.E180K | COAD | 1 |
| p.A190S | LUAD | 1 |
| p.S408F | SKCM | 1 |
| p.R445H | CESC | 1 |
| p.E120X | COAD | 1 |
| p.S460F | SKCM | 1 |
| p.E153Q | BLCA | 1 |
| p.L187V | PCPG | 1 |
| p.T226K | THYM | 1 |
| p.S430F | SKCM | 1 |
| p.S89L | UCEC | 1 |
| p.I249N | SKCM | 1 |
| p.R372H | HNSC | 1 |
| p.R424H | PRAD | 1 |
| p.E205Q | BLCA | 1 |
| p.S378F | SKCM | 1 |
| p.A466T | UCEC | 1 |
| p.R196L | KIRC | 1 |
| p.R269T | BLCA | 1 |
| p.L239V | PCPG | 1 |
| p.S143F | PAAD | 1 |
| p.R43M | PRAD | 1 |
| p.L407M | UCEC | 1 |
| p.M397I | SKCM | 1 |
| p.V475I | ESCA | 1 |
| p.E391Q | LUAD | 1 |
| p.R43S | PRAD | 1 |
| p.A70V | LUAD | 1 |
| p.P511L | SKCM | 1 |
| p.E305Q | LUAD | 1 |
| p.R167W | PAAD | 1 |
| p.P130S | SKCM | 1 |
| p.P459L | SKCM | 1 |
| p.R424H | HNSC | 1 |
| p.E253Q | LUAD | 1 |
| p.E398K | SKCM | 1 |
| p.E288K | LUAD | 1 |
| p.E75K | BLCA | 1 |
| p.P526L | SKCM | 1 |
| p.P374S | STAD | 1 |
| p.V527I | PRAD | 1 |
| p.R219W | PAAD | 1 |
| p.Q509* | HNSC | 1 |
| p.P182S | SKCM | 1 |
| p.R424H | LGG | 1 |
| p.V527I | ESCA | 1 |
| p.L268F | OV | 1 |
| p.E377Q | BLCA | 1 |
| p.R202C | PRAD | 1 |
| Top |
| TissGeneCNV for TRAF2 |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for TRAF2 |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | BI031313 | TRAF2-DENND1C | chr9:139820247 | chr19:6475907 |
| Top |
| TissGeneNet for TRAF2 |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| TRAF2, FADD, RUVBL2, DVL2, TRIP6, TNFRSF14, ZNF205, RUVBL1, TRAIP, TAB1, UBXN11, TCEA2, EPS15, RGS14, BAHD1, TNFRSF18, SPHK1, ZNF646, FBF1, BANP, CCDC130 (tumor) | TRAF2, RUVBL2, IKBKG, CDK9, PIN1, TNFRSF14, GSK3B, MAP3K11, STUB1, EP300, ZNF205, TRADD, TNFRSF4, PKN1, PFKL, THAP7, AFF4, TNFRSF25, LZTS2, MAP4K3, CCDC130 (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| TRAF2, IKBKE, MAP3K5, CRY1, CDK9, MAP3K11, SPATA2, SMURF1, BAG2, DAB2IP, HIVEP3, CAV1, TRAF3, TRADD, RHEB, AASDHPPT, ZMYND11, EDARADD, TNFRSF11A, ZNF646, MAP4K3 (tumor) | TRAF2, IKBKG, CDK9, NRIP1, TNFRSF14, GSK3B, TANK, STUB1, ZNF205, RHEBL1, CDCA3, MAST2, TRADD, UBXN11, AASDHPPT, AFF4, TNFRSF25, IPO11, MAP4K3, FBF1, CHMP2B (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| TRAF2, FADD, MAP3K7, IKBKG, TRIP6, CDK9, MAPK9, TNFRSF14, TRIM37, APPL1, LTBR, PIAS2, HSPA9, TRADD, RPS6KA3, ZBTB25, EPS15, NECAP2, MAP4K3, BANP, CCDC130 (tumor) | TRAF2, GORASP2, MAP4K5, PIN1, TNFRSF14, MAP3K14, CALM1, ZNF205, ATXN1, RHEBL1, CLTC, TRAIP, UBXN11, ANKRD36BP1, RIBC2, ERN1, NECAP2, AFF4, MAP4K3, FATE1, ABLIM1 (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| TRAF2, MAP3K5, DVL2, CDK9, UBE2N, MAP3K11, CHUK, SLC25A5, CYLD, ZNF205, ATXN1, TRAF3, CAD, SIAH2, RHEB, AIMP2, IFIT3, NGFRAP1, LZTS2, APIP, USP31 (tumor) | TRAF2, CRY1, RUVBL2, MAP3K7, CDK9, MAP3K11, STUB1, ZNF205, CLTC, TAB2, ANKRD36BP1, CDC40, TCEA2, RAD23A, CFLAR, THAP7, AFF4, FAM120B, TAOK3, TRPT1, CCDC130 (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| TRAF2, FADD, DVL2, CDK9, MAPK9, MAP3K11, ZNF205, CLTC, LTBR, TAB1, LNX1, TRADD, CALM3, TNFRSF13B, TNFRSF18, CFLAR, CD27, FAM120B, LZTS2, APIP, APEX2 (tumor) | TRAF2, RUVBL2, IKBKG, CDK9, TRAF1, PIN1, TNFRSF14, MAP3K11, CHUK, ZNF205, APPL1, TAB1, UBXN11, ZMYND11, RAD23A, TNFRSF18, THAP7, AFF4, IPO11, LZTS2, CCDC130 (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| TRAF2, DVL2, CDK9, CASP1, CALM1, TNF, CHUK, SLC25A5, TUBB, TNFRSF1B, ZNF205, PIAS2, CAD, HSPA9, CD40, USP2, TNFRSF18, TRAF3IP2, LZTS2, TNFSF14, DLGAP5 (tumor) | TRAF2, TRAF6, MAP3K7, CDK9, GSK3B, MAP3K11, ZNF205, APPL1, CLTC, LTBR, PIAS2, MTOR, UBXN11, ZMYND11, RAD23A, ERN1, THAP7, AFF4, FAM120B, CHMP2B, CCDC130 (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| TRAF2, TRIP6, TRIM31, NUDT18, TNFRSF14, PARK2, APPL1, EEF1A2, SALL1, TAB2, TRADD, TNFRSF4, TCEA2, ZMYND11, TNFRSF18, PEG3, SOX9, SPHK1, GSTP1, TAB3, CCDC130 (tumor) | TRAF2, IKBKE, TRAF6, CDK9, TRIM31, NRIP1, ZNF205, RHEBL1, CDCA3, UBE2Z, NAP1L1, TRAIP, UBXN11, TNFRSF4, RPL23, RIBC2, ERN1, TNFRSF18, SPHK1, MYLK2, DLGAP5 (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| TRAF2, TRIP6, TRAF1, FBXO28, MAPK9, TBK1, MAP3K11, CHUK, ZNF205, UBQLN4, PIAS2, TAB1, LNX1, TRADD, TNFRSF4, PKN1, RGS14, LZTS2, MAP4K3, BANP, CHMP2B (tumor) | TRAF2, CDK9, MAP3K11, SMURF2, ZNF205, TNIK, ATXN1, FXR2, LTBR, IFNAR1, SPRY2, CDC40, TNFRSF4, GOLGA3, EPS15, KIAA0408, TNFRSF25, IPO11, LZTS2, BANP, CCDC130 (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| TRAF2, RUVBL2, IKBKG, TRIP6, CDK9, PIN1, MAP3K14, MAP3K11, ZNF205, FXR2, TRADD, CDC40, AASDHPPT, EPS15, PKN1, PFKL, BAHD1, TNFRSF18, ZNF646, LZTS2, FBF1 (tumor) | TRAF2, IKBKE, BIRC3, CDK9, TRAF1, ZBTB43, TNFRSF14, MAP3K14, CALM1, MAP3K11, TNFAIP3, ZNF205, DAB2IP, AASDHPPT, TNFRSF4, GOLGA3, IL15RA, TNFRSF25, IPO11, MAP4K3, CCDC130 (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| TRAF2, RUVBL2, MAP3K7, TNFRSF14, HSPA1B, MAP3K11, CASP8AP2, ZNF205, APPL1, LTBR, RB1CC1, ANKRD36BP1, RPL23, DIABLO, ERN1, TNFRSF18, PEG3, CFLAR, QARS, IPO11, CCDC130 (tumor) | TRAF2, RUVBL2, CDK9, MAP3K11, CHUK, STUB1, EP300, ZNF205, PIAS2, UBXN11, ANKRD36BP1, HTRA2, TCEA2, ZMYND11, EPS15, RAD23A, USP53, TNFRSF18, THAP7, AFF4, CCDC130 (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| TRAF2, IKBKE, CALM1, RIPK3, TRPC4AP, PARK2, CAV1, TRAIP, TRADD, RHEB, ZMYND11, RGS14, EDARADD, PFKL, TNFRSF18, NECAP2, QARS, TRAF3IP2, GCKR, DLGAP5, APEX2 (tumor) | TRAF2, IKBKE, MAP4K5, CDK9, CALM1, TANK, MAP3K11, SPATA2, ZNF205, RHEBL1, CDCA3, CAV1, LTBR, TRAIP, RPS6KA3, ZMYND11, EPS15, PEG3, KIAA0408, AFF4, MAP4K3 (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| TRAF2, FADD, RUVBL2, MAP3K7, MAP4K5, ZBTB43, FBXO28, NUDT18, BIRC2, SMURF2, EP300, RB1CC1, PIAS2, RGS14, THAP7, QARS, AFF4, APEX2, TAB3, WDR65, ABLIM1 (tumor) | TRAF2, RUVBL2, MAP3K7, MAP4K5, FBXO28, NUDT18, GSK3B, ZNF205, TNIK, CLTC, RB1CC1, UBXN11, ANKRD36BP1, RPS6KA3, TCEA2, USP53, THAP7, AFF4, TAB3, TRPT1, CCDC130 (normal) |
 |  |
| Top |
| TissGeneProg for TRAF2 |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for TRAF2 |
| TissGeneDrug for TRAF2 |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for TRAF2 |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0024530 | Malaria | 5 | BeFree |
| umls:C0017636 | Glioblastoma | 3 | BeFree |
| umls:C0023467 | Leukemia, Myelocytic, Acute | 3 | BeFree |
| umls:C0235974 | Pancreatic carcinoma | 3 | BeFree |
| umls:C0346647 | Malignant neoplasm of pancreas | 3 | BeFree |
| umls:C0002395 | Alzheimer's Disease | 2 | GAD |
| umls:C0006142 | Malignant neoplasm of breast | 2 | BeFree |
| umls:C0007134 | Renal Cell Carcinoma | 2 | BeFree |
| umls:C0007137 | Squamous cell carcinoma | 2 | BeFree |
| umls:C0019693 | HIV Infections | 2 | BeFree,GAD |
| umls:C0021368 | Inflammation | 2 | GAD |
| umls:C0023434 | Chronic Lymphocytic Leukemia | 2 | BeFree |
| umls:C0024141 | Lupus Erythematosus, Systemic | 2 | BeFree |
| umls:C0024299 | Lymphoma | 2 | BeFree |
| umls:C0024623 | Malignant neoplasm of stomach | 2 | BeFree |
| umls:C0026764 | Multiple Myeloma | 2 | BeFree,GAD |
| umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
| umls:C0151526 | Premature Birth | 2 | GAD |
| umls:C0242379 | Malignant neoplasm of lung | 2 | BeFree |
| umls:C0398689 | Hyper-IgM Immunodeficiency Syndrome, Type 1 | 2 | BeFree |
| umls:C0678222 | Breast Carcinoma | 2 | BeFree |
| umls:C0684249 | Carcinoma of lung | 2 | BeFree |
| umls:C0699791 | Stomach Carcinoma | 2 | BeFree |
| umls:C0002871 | Anemia | 1 | BeFree |
| umls:C0003873 | Rheumatoid Arthritis | 1 | BeFree |
| umls:C0004096 | Asthma | 1 | BeFree |
| umls:C0007102 | Malignant tumor of colon | 1 | BeFree |
| umls:C0009782 | Connective Tissue Diseases | 1 | GAD |
| umls:C0015929 | Fetal Diseases | 1 | GAD |
| umls:C0016057 | Fibrosarcoma | 1 | BeFree |
| umls:C0016169 | pathologic fistula | 1 | BeFree |
| umls:C0016629 | Fowlpox | 1 | BeFree |
| umls:C0017638 | Glioma | 1 | LHGDN |
| umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | GAD |
| umls:C0024535 | Malaria, Falciparum | 1 | BeFree |
| umls:C0025202 | melanoma | 1 | BeFree |
| umls:C0025500 | Mesothelioma | 1 | BeFree |
| umls:C0026857 | Musculoskeletal Diseases | 1 | GAD |
| umls:C0029408 | Degenerative polyarthritis | 1 | BeFree |
| umls:C0029882 | Otitis Media | 1 | BeFree |
| umls:C0030297 | Pancreatic Neoplasm | 1 | BeFree |
| umls:C0032927 | Precancerous Conditions | 1 | BeFree |
| umls:C0032964 | Pregnancy Complications, Hematologic | 1 | GAD |
| umls:C0035344 | Retinopathy of Prematurity | 1 | GAD |
| umls:C0037274 | Dermatologic disorders | 1 | GAD |
| umls:C0039103 | Synovitis | 1 | BeFree |
| umls:C0042900 | Vitiligo | 1 | BeFree |
| umls:C0079731 | B-Cell Lymphomas | 1 | LHGDN |
| umls:C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | BeFree |
| umls:C0085400 | Neurofibrillary degeneration (morphologic abnormality) | 1 | BeFree |
| umls:C0149925 | Small cell carcinoma of lung | 1 | BeFree |
| umls:C0152013 | Adenocarcinoma of lung (disorder) | 1 | BeFree |
| umls:C0155094 | Corneal pannus | 1 | BeFree |
| umls:C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 1 | BeFree |
| umls:C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 1 | BeFree |
| umls:C0265808 | Cyanotic congenital heart disease | 1 | BeFree |
| umls:C0278883 | Metastatic melanoma | 1 | BeFree |
| umls:C0333516 | Tumor necrosis | 1 | BeFree |
| umls:C0376154 | Skin callus | 1 | BeFree |
| umls:C0376358 | Malignant neoplasm of prostate | 1 | BeFree |
| umls:C0393576 | Chorea Acanthocytosis Syndrome | 1 | BeFree |
| umls:C0432487 | Post-transplant lymphoproliferative disorder | 1 | BeFree |
| umls:C0596263 | Carcinogenesis | 1 | BeFree |
| umls:C0600139 | Prostate carcinoma | 1 | BeFree |
| umls:C0677886 | Epithelial ovarian cancer | 1 | BeFree |
| umls:C0699790 | Colon Carcinoma | 1 | BeFree |
| umls:C0699885 | Carcinoma of bladder | 1 | BeFree |
| umls:C0810032 | Pancreatic disorders (not diabetes) | 1 | BeFree |
| umls:C0855095 | Small Lymphocytic Lymphoma | 1 | BeFree |
| umls:C0872054 | latent infection | 1 | BeFree |
| umls:C0919267 | ovarian neoplasm | 1 | BeFree |
| umls:C1302547 | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 1 | BeFree |
| umls:C1704216 | Basaloid carcinoma | 1 | BeFree |
| umls:C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 1 | BeFree |
| umls:C2745900 | Promyelocytic leukemia | 1 | BeFree |
| umls:C2827407 | Infectious Otitis Media | 1 | BeFree |
| umls:C2931822 | Nasopharyngeal carcinoma | 1 | BeFree |
| umls:C3495801 | Granulomatosis with polyangiitis | 1 | BeFree |
| umls:C3714514 | Infection | 1 | GAD |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |